RK

Active Director Director DIN 10089910
DIN 10089910 First appointment Mar 2023 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Mar 2023
Shareholding value Locked Premium profile

About Ravi Kant

Data last updated:

Ravi Kant has 3 years in corporate governance. Holds Director role. Currently with 1 company, including Ayubest Healthcare Private Limited. Engaged in Healthcare. Contributes to corporate operations.

DIN 10089910
Primary Designation Director
First Appointment 27 Mar 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedStatus
Ayubest Healthcare Private Limited U21003DL2023PTC411650
Director27 Mar 20232023Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ayubest Healthcare Private Limited
Premium access

Shareholding and investment profile for Ravi Kant

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravi Kant

Ravi Kant has 3 years in corporate governance. Holds Director role. Currently with 1 company, including Ayubest Healthcare Private Limited. Engaged in Healthcare. Contributes to corporate operations.

Ravi Kant is associated with 1 company as Director.

Ravi Kant has expertise in Healthcare.

Ravi Kant has 3 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available